Great Point Partners LLC

Investment Strategy

Great Point Partners specializes in lower middle market growth buyout funds for private health care companies and manages a hedge fund focusing on public life sciences companies. The firm targets investments in growing, profitable health care businesses led by management teams aiming for accelerated, sustainable growth. GPP’s private equity strategy emphasizes growth equity, recapitalizations, and management buyouts, with a focus on biopharmaceutical services and supplies, alternate site care, medical device manufacturing, and information technology-enabled businesses. Its public equity strategy (BioMedical Value Fund) uses a deep value, fundamentally focused approach targeting small- and mid-cap publicly traded biotech/life sciences companies with innovative technology. Across strategies, GPP employs a proactive sourcing model and partners closely with management teams through strategic, operational, and financial support.